Jul 17, 2017 by Brian Feroldi, Reuben Gregg Brewer, and Keith NoonanRoundtable: 1 Underdog Stock I'm WatchingAlliance Resource Partners, GameStop, and Coherus BioSciences are all in turnaround mode. Can they make it happen, or are they destined to keep falling from here?
Jul 13, 2017 by Brian FeroldiHere's Why Alder Biopharmaceuticals Inc Stock Is Bouncing BackShares popped after the company released the pricing details of its recently announced stock offering.
Jul 13, 2017 by Brian FeroldiThe Fastest Growing Cancer Company You've Never Heard OfThis small-cap cancer company is growing at triple-digit growth rates and has a massive opportunity for expansion ahead.
Jul 12, 2017 by Brian Feroldi, Reuben Gregg Brewer, and Keith Noonan3 Growth Stocks for Canny InvestorsHere's why growth investors should put Camping World Holdings, Facebook, and HubSpot on their radar.
Jul 12, 2017 by Brian Feroldi, Travis Hoium, and John Rosevear3 Value Stocks for Your Golden YearsHere's why our team of investors thinks these three stocks are tailor-made for retirees.
Jul 12, 2017 by Brian FeroldiWhy Alder Biopharmaceuticals Inc Is Sinking TodayShares drop after the company announces a dilutive secondary share offering.
Jul 12, 2017 by Brian Feroldi, Rich Duprey, and Demitri Kalogeropoulos3 Tech Stocks for JulyLooking for a few great tech stocks to power your portfolio higher this summer? Here's why you should check out Cirrus Logic, Netflix, and IPG Photonics.
Jul 11, 2017 by Brian Feroldi, Sean Williams, and George Budwell, PhD3 Top Healthcare Stocks to Buy TodayHere's why our healthcare experts think that Bristol-Myers Squibb, Celgene, and Mazor Robotics are all great buys right now.
Jul 11, 2017 by Brian Feroldi, Sean Williams, and George Budwell, PhD3 Dividend Stocks in HealthcareHere's why income investors should take a hard look at AstraZeneca, Medtronic, and Abbvie.
Jul 11, 2017 by Brian FeroldiWhy TherapeuticsMD Inc Is Soaring TodayShares jump in response to an analyst upgrade.
Jul 10, 2017 by Brian Feroldi, Travis Hoium, and John Rosevear3 High-Yield Dividend Stocks for In-the-Know InvestorsLooking for a few high-yield stocks? Here's why you should check out General Motors, Pattern Energy Group, and Brookfield Infrastructure Partners.
Jul 10, 2017 by Brian FeroldiWhy Myriad Genetics Stock Rocketed 26.3% Higher in JuneInvestors bid up the company's share price after it released a series of positive clinical updates.
Jul 10, 2017 by Brian FeroldiWhy CRISPR Therapeutics AG Jumped 11.7% in JuneShares rose after the company shared two pieces of good news with investors.
Jul 10, 2017 by Brian FeroldiWhy Intrexon Stock Rose 10.4% in JuneIt was another busy month for the synthetic biology company.
Jul 10, 2017 by Brian FeroldiHere's Why Organovo Holdings Inc Fell 10.5% in JuneShares dropped after the company reported uninspiring fourth-quarter results.
Jul 10, 2017 by Brian FeroldiWhy Mazor Robotics Dropped 15.6% in JuneShares plunged after investors learned that a state agency has been conducting searches at the company's office.
Jul 7, 2017 by Brian Feroldi, Reuben Gregg Brewer, and Keith Noonan3 Growth Stocks for Ambitious InvestorsOn the hunt for a few stocks that hold upside potential? Here's why you should put Buckeye Partners, Weibo, and Align Technology on your radar.
Jul 6, 2017 by Brian Feroldi, Rich Duprey, and Demitri Kalogeropoulos3 Stocks That Could Put Alibaba's Returns to ShameOn the hunt for a few growth stocks that hold massive upside potential? Consider giving these three gems a closer look.
Jul 6, 2017 by Brian FeroldiIn Your 70s? 3 Stocks You Might Want to BuyPfizer, STORE Capital, and National Grid all look like timely buys for conservative investors.
Jul 3, 2017 by Brian Feroldi3 Best-Performing Stocks in JuneHere's why Signet Jewelers Limited, Alexion Pharmaceuticals, and Acuity Brands all posted gains of 20% or more during the month.
